Xenobiotic metabolism and gut microbiomes

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Das, Anubhav ^a   Srinivasan, Meenakshi ^b   Ghosh, Tarini Shankar ^a   Mande, Sharmila S ^a  

^a TATA CONSULTANCY SERVICES   (India)

^b MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING); CYTOCHROME P450; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; THIOPURINE METHYLTRANSFERASE; XENOBIOTIC AGENT; ENZYME;

ADOLESCENT; ADULT; AGE; AMERICAN; ARTICLE; BACILLUS; BACTEROIDES; BRADYRHIZOBIUM; CHILD; CHINESE; DANISH CITIZEN; DRUG USE; ESCHERICHIA; EUBACTERIUM; FAECALIBACTERIUM; FRENCHMAN; GENETIC VARIATION; GEOGRAPHY; HUMAN; INDIAN; INFANT; INTESTINE FLORA; ITALIAN (CITIZEN); JAPANESE (PEOPLE); METAGENOME; METHYLOBACTERIUM; NEISSERIA; NEWBORN; PHARMACOKINETICS; PRESCHOOL CHILD; PREVOTELLA; RACE DIFFERENCE; RHIZOBIUM; RHODOPSEUDOMONAS; RHODOSPIRILLUM; RUMINOCOCCUS; SCHOOL CHILD; SPANIARD; TAXONOMY; TREPONEMA; XENOBIOTIC METABOLISM; AGED; BACTERIUM; CLASSIFICATION; DRUG INACTIVATION; ENZYMOLOGY; ETHNIC GROUP; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BACTERIA; CHILD; CHILD, PRESCHOOL; ENZYMES; ETHNIC GROUPS; FEMALE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INACTIVATION, METABOLIC; INFANT; INFANT, NEWBORN; MALE; METABOLIC NETWORKS AND PATHWAYS; METAGENOME; MIDDLE AGED; XENOBIOTICS;

EID: 84991246902     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163099     Document Type: Article

References (70)

1. OECD (2012) "Pharmaceutical consumption", in Health at a Glance: Europe 2012, OECD Publishing. DOI: http://dx.doi.org/10.1787/9789264183896-38-en
2. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 1992; 22:1-21. doi: 10.3109/10408449209145319 PMID: 1616599
3. Jakoby WB, Ziegler DM. The enzymes of detoxification. J Biol Chem. 1990; 265: 20715-20718. PMID: 2249981
4. Ishizuka T, Fujimori I, Kato M, Noji-Sakikawa C, Saito M, Yoshigae Y, et al. Human carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartanmedoxomil in liver and intestine. J. Biol. Chem. 2010; 285: 11892-11902. doi: 10.1074/jbc.M109.072629 PMID: 20177059
5. Kazui M. Identification of the human cytochrome p450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. DrugMetab. Dispos. 2010; 38: 92-99. doi: 10.1124/dmd.109.029132 PMID: 19812348
6. Grilo NM, Charneira C, Pereira SA, Monteiro EC, Marques MM, Antunes AM. Bioactivation to an aldehyde metabolite-possible role in the onset of toxicity induced by the anti-HIV drug abacavir. Toxicol. Lett. 2014; 224: 416-423. doi: 10.1016/j.toxlet.2013.10.036 PMID: 24211422
7. Laine JE, Auriola S, Pasanen M, Juvonen RO. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica 2009; 39: 11-21. doi: 10.1080/00498250802512830 PMID: 19219744
8. Goodman LS, Brunton LL, Chabner B, Knollmann BC. Goodman & Gilman's Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill; 2011.
9. Ma Q, Lu AY. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev. 2011; 63: 437-459. doi: 10.1124/pr.110.003533 PMID: 21436344
10. Saad R, Rizkallah MR, Aziz RK. Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes; Gut Pathogens. 2012; 4: 16. doi: 10.1186/1757-4749-4-16 PMID: 23194438
11. Claus SP, Ellero SL, Berger B, Krause L, Bruttin A, Molina J, et al. Colonization-induced host-gut microbial metabolic interaction. Mbio 2011; 2: e00271-10. doi: 10.1128/mBio.00271-10 PMID: 21363910
12. Grundmann O. The gut microbiome and pre-systemic metabolism: current state and evolving research. J. Drug Metab. Toxicol. 2010; 1: 104. doi: 10.4172/2157-7609.1000104
13. Li H, Jia W. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity. Nature 2013; 94: 1-8.
14. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359. doi: 10.1126/science.1124234 PMID: 16741115
15. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA. 2011; 108: 3047-3052. doi: 10.1073/pnas.1010529108 PMID: 21282636
16. Al-Asmakh M, Anuar F, Zadjali F, Rafter J, Pettersson S. Gut microbial communities modulating brain development and function. Gut Microbes. 2012; 3: 366-373. doi: 10.4161/gmic.21287 PMID: 22743758
17. Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. The intestinalmicrobiome in early life: health and disease. Front Immunol. 2014; 5: 427. doi: 10.3389/fimmu.2014.00427 PMID: 25250028
18. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014; 20: 159-166. doi: 10.1038/nm.3444 PMID: 24390308
19. Caesar R, Fåk F, Bäckhed F. Effects of gut microbiota on obesity andatherosclerosis via modulation of inflammation and lipid metabolism. J. Intern.Med. 2010; 268: 320-328. doi: 10.1111/j.1365-2796. 2010.02270.x PMID: 21050286
20. Rowland IR. Interactions of the gut microflora and the host in toxicology. Toxicol. Pathol. 1988; 16: 147-153. doi: 10.1177/019262338801600207 PMID: 3055224
21. Lhoste EF, Ouriet V, Bruel S, Flinois JP, Brézillon C, Magdalou J, et al. The human colonic microflora influences the alterations of xenobiotic metabolizing enzymes by catechins in male F344 rats. Food Chem. Toxicol. 2003; 41: 695-702. doi: 10.1016/s0278-6915(03)00010-3 PMID: 12659723
22. Bowey E, Adlercreutz H, Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. FoodChem. Toxicol. 2003; 41: 631-636. doi: 10.1016/s0278-6915(02)00324-1 PMID: 12659715
23. Strong HA, Renwick AG, George CF, Liu YF, Hill MJ. The reduction of sulphinpyrazone and sulindac by intestinal bacteria. Xenobiotica. 1987; 17: 685-96. doi: 10.3109/00498258709043976 PMID: 3630204
24. Drasar BS, Renwick AG, Williams RT. The role of the gut flora in the metabolism of cyclamate. Biochem J. 1972; 129: 881-890. doi: 10.1042/bj1290881 PMID: 4655823
25. Shu YZ, Kingston DG, Van Tassell RL, Wilkins TD. Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria. Xenobiotica. 1991; 21: 737-750. doi: 10.3109/00498259109039513 PMID: 1949905
26. Selma MV, Espín JC, Tomás-Barberán FA. Interaction between phenolics and gutmicrobiota: role in human health. J. Agric. Food Chem. 2009; 57: 6485-6501. doi: 10.1021/jf902107d PMID: 19580283
27. Koch RL, Beaulieu BB Jr, Goldman P. Role of the intestinal flora in the metabolism of misonidazole. Biochem. Pharmacol. 1980; 29: 3281-3284. doi: 10.1016/0006-2952(80)90304-4 PMID: 6260109
28. Koch RL, Chrystal EJ, Beaulieu BB Jr, Goldman P. Acetamide - a metabolite of metronidazole formed by the intestinal flora. Biochem Pharmacol. 1979; 28: 3611-3615. PMID: 231450
29. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19: 576-585. doi: 10.1038/nm.3145 PMID: 23563705
30. Smith HF, Parker W, Kotzé SH, Laurin M. Multiple independent appearances of the cecal appendix in mammalian evolution and an investigation of related ecological and anatomical factors. Comptes Rendus Palevol 2013; 12: 339-354. doi: 10.1016/j.crpv.2012.12.001
31. Nguyen TL, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research? Dis Model Mech. 2015; 8: 1-16. doi: 10.1242/dmm.017400 PMID: 25561744
32. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102: 11070-11075. doi: 10.1073/pnas.0504978102 PMID: 16033867
33. Lee WJ, Lattimer LDN, Stephen S, Borum ML, Doman DB. Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterlogy&Hepatology. 2015; 11:24-32. PMID: 27099570
34. Mathan VI, Wiederman J, Dobkin JF, Lindenbaum J. Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut. 1989; 30: 971-977. doi: 10.1136/gut.30.7.971 PMID: 2759492
35. Rafii F, Jackson LD, Ross I, Heinze TM, Lewis SM, Aidoo A, et al. Metabolism of daidzein by fecal bacteria in rats. Comp Med. 2007; 57: 282-286. PMID: 17605343
36. Amann RI, Ludwig W, Schleifer KH. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 1995; 59: 143-169. PMID: 7535888
37. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480-484. doi: 10.1038/nature07540 PMID: 19043404
38. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55-60. doi: 10.1038/nature11450 PMID: 23023125
39. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013; 498: 99-103. doi: 10.1038/nature12198 PMID: 23719380
40. Gupta SS, Mohammed MH, Ghosh TS, Kanungo S, Nair GB, Mande SS. Metagenome of the gut of a malnourished child. Gut Pathogens 2011; 3: 7. doi: 10.1186/1757-4749-3-7 PMID: 21599906
41. Ghosh TS, Gupta SS, Bhattacharya T, Yadav D, Barik A, Chowdhury A, et al. Gut microbiomes of Indian children of varying nutritionalstatus. PLoS One. 2014; 9: e95547. doi: 10.1371/journal.pone. 0095547 PMID: 24763225
42. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010; 464: 59-65. doi: 10.1038/nature08821 PMID: 20203603
43. Ghosh TS, Gupta SS, Nair GB, Mande SS. In silico analysis of antibiotic resistance genes in the gut microflora of individuals from diverse geographiesand age-groups. PLoS One. 2013; 8: e83823. doi: 10.1371/journal.pone.0083823 PMID: 24391833
44. Hu Y, Yang X, Qin J, Lu N, Cheng G, Wu N, et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 2013; 4: 2151. doi: 10.1038/ncomms3151 PMID: 23877117
45. Forslund K, Sunagawa S, Kultima JR, Mende DR, Arumugam M, Typas A, et al. Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 2013; 23: 1163-1169. doi: 10.1101/gr.155465.113 PMID: 23568836
46. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012; 486: 222-227. doi: 10.1038/nature11053 PMID: 22699611
47. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011; 473: 174-180. doi: 10.1038/nature09944 PMID: 21508958
48. Bhattacharya T, Ghosh TS, Mande SS. Global Profiling of Carbohydrate Active Enzymes in Human Gut Microbiome. PLoS One. 2015; 10:e0142038. doi: 10.1371/journal.pone.0142038 PMID: 26544883
49. Penner N, Woodward C, Prakash C. Drug metabolizing enzymes and biotransformation reactions. In: Zhang D. and Surapaneni S., editors. ADME-Enabling Technologies in Drug Design and Development. Austin: John Wiley and sons Inc; 2012. pp.545-565.
50. Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010; 154(2):103-16. doi: 10.5507/bp.2010.017 PMID: 20668491
51. Nash DB. The Use of Medicines in the United States: A Detailed Review. American Health & Drug Benefits. 2012; 5: 423. PMID: 24991338
52. Tamames J, Abellán JJ, Pignatelli M, Camacho A, Moya A. Environmental distribution of prokaryotic taxa. BMC Microbiol. 2010; 10:85. doi: 10.1186/1471-2180-10-85 PMID: 20307274
53. Shah RR. Pharmacogenetics, ethnic differences in drug response and drug regulation. In: Suarez-Kurtz G, editor. Pharmacogenomics in admixed populations. Austin: Landes Bioscience; 2007. pp.180-197
54. Yasuda SU, Zhang L, Huang SM. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin. Pharmacol. Ther. 2008; 84: 417-423. doi: 10.1038/clpt.2008.141 PMID: 18615002
55. Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi Pharm J. 2014; 22: 83-94. doi: 10.1016/j.jsps.2013.02.003 PMID: 24648818
56. Smyth RM, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children - a systematic review. PLoS One. 2012; 7: e24061. doi: 10.1371/journal.pone.0024061 PMID: 22403604
57. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr. Pharmacother. 2003; 1: 82-89. doi: 10.1016/s1543-5946 (03)90004-3 PMID: 15555470
58. Tedjo DI, Jonkers DM, Savelkoul PH, Masclee AA, van Best N, Pierik MJ, et al. The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects. PLoS One. 2015; 10:e0126685. doi: 10.1371/journal.pone.0126685 PMID: 26024217
59. Cardona S, Eck A, Cassellas M, Gallart M, Alastrue C, Dore J, et al. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol. 2012; 12:158. doi: 10.1186/1471-2180-12-158 PMID: 22846661
60. Springael D, Top EM. Horizontal gene transfer and microbial adaptation to xenobiotics: new types of mobile genetic elements and lessons from ecological studies. Trends Microbiol. 2014; 12: 53-58.
61. van der Meer JR, de Vos WM, Harayama S, Zehnder AJ. Molecular mechanisms of genetic adaptation to xenobiotic compounds. Microbiol Rev. 1992; 56: 677-694. PMID: 1480115
62. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486: 207-214. doi: 10.1038/nature11234 PMID: 22699609
63. Ghosh TS, Haque MM, Mande SS. DiScRIBinATE: a rapid method foraccurate taxonomic classification of metagenomic sequences. BMC Bioinformatics. 2010; 11: S14. doi: 10.1186/1471-2105-11-S7-S14 PMID: 21106121
64. Parks DH, Beiko RG. Identifying biologically relevant differences between metagenomic communities. Bioinformatics. 2010 Mar 15; 26(6):715-21. doi: 10.1093/bioinformatics/btq041 PMID: 20130030
65. Devos D, Valencia A. Practical limits of function prediction. Proteins: Struct. Funct. Genet. 2000; 41: 98-107. doi: 10.1002/1097-0134(20001001)41:1%3C98::aid-prot120%3E3.3.co;2-j
66. Wilson CA, Kreychman J, Gerstein M. Assessing annotation transfer for genomics: quantifying the relations between protein sequence, structure and function through traditional andprobabilistic scores. J. Mol. Biol. 2000; 297: 233-249. doi: 10.1006/jmbi.2000.3550 PMID: 10704319
67. Todd AE, Orengo CA, Thornton JM. Evolution of function in superfamilies, from a structural perspective. J. Mol. Biol. 1999; 307: 1113-1143.
68. Haque MM, Ghosh TS, Komanduri D, Mande SS. SOrt-ITEMS: Sequence orthology based approach for improved taxonomic estimation of metagenomic sequences. Bioinformatics. 2009; 25:1722-1730. doi: 10.1093/bioinformatics/btp317 PMID: 19439565
69. Ghosh TS, Haque MM, Komanduri D, Mande SS. ProViDE: A software tool for accurate estimation of viral diversity in metagenomic samples. Bioinformation. 2011; 6:91-94. doi: 10.6026/97320630006091 PMID: 21544173
70. Peabody MA, Van Rossum T, Lo R, Brinkman FS. Evaluation of shotgun metagenomics sequence classification methods using in silico and in vitro simulated communities. BMC Bioinformatics. 2015; 16:363. doi: 10.1186/s12859-015-0788-5 PMID: 26537885